N/a
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine
-Jun 03 2020: MRNA in top 5 pick for vaccine candidate
-SPY pattern: Runner
-Intraday pattern: Afternoon Runner
-Levels: 63.5 - 64, 65, 66, 67
Strategy: First test long of 66 level
Confluence: Whole $
Strike Zone: 66.2 - 65.9
Sizing (lots): 3 (could only do 2 because of margin requirements)
Risk (stop / Rs): Hold below 66
OGT, the bounce was weak so I scaled out when I could, gave 10 minutes for trade to work which is ample time.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-06-15 15:05:15 | MRNA | buy | $66.100 | long |
2020-06-15 15:05:20 | MRNA | buy | $66.130 | long |
2020-06-15 15:05:20 | MRNA | buy | $66.130 | long |
2020-06-15 15:07:19 | MRNA | sell | $66.250 | long |
2020-06-15 15:10:22 | MRNA | sell | $66.190 | long |
2020-06-15 15:11:52 | MRNA | sell | $66.210 | long |
2020-06-15 15:13:02 | MRNA | sell | $66.263 | long |
2020-06-15 15:14:21 | MRNA | sell | $66.403 | long |
2020-06-15 15:15:07 | MRNA | sell | $66.383 | long |
2020-06-15 15:16:24 | MRNA | sell | $66.300 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!